Azeria Therapeutics, the World's First Pioneer Factor Drug Discovery Company, Announces Series A Investment from Sixth Element Capital

CAMBRIDGE, England, September 4, 2018 -- (Healthcare Sales & Marketing Network) -- Azeria Therapeutics Limited, a newly formed drug discovery company, today announced that it has successfully raised £4 million in Series A fundraising from the £... Biopharmaceuticals, Oncology, Venture Capital Azeria Therapeutics, FOXA1
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news